Biotechnology · Healthcare
CEO, Board Member
2009-01-01–present
Board Member
Aura Biosciences, Inc. (AURA)Equibles does not estimate personal net worth.
Get an email with a short summary when Aura Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get AURA alertsElisabet de los Pinos is recorded as Board Member at Aura Biosciences, Inc. (AURA) since January 1, 2009 and CEO at Aura Biosciences, Inc. (AURA). The newest filing on record that lists Elisabet de los Pinos as CEO and Board Member at Aura Biosciences, Inc. (AURA) is dated April 20, 2026. The proxy statement of Aura Biosciences, Inc. reports total compensation of $6,816,256 for Elisabet de los Pinos in fiscal 2021, including a base salary of $431,816. Disclosed compensation is on record for 2 fiscal years. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aura Biosciences, Inc. includes Natalie Holles (CEO and Board Member), Amy Elazzouzi (CFO and Chief Accounting Officer), Anthony Gibney (CFO) and 7 others.
2009-01-01–present
Last confirmed April 20, 2026
Start not stated–present
Last confirmed April 20, 2026
Biotechnology · Healthcare
CEO, Board Member
2009-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Aura Biosciences, Inc. (AURA) | President, Chief Executive Officer and Director | $431,816 | $6,816,256 |
| 2020 | Aura Biosciences, Inc. (AURA) | President, Chief Executive Officer and Director | $394,890 | $1,094,900 |
No call appearances or filed executive changes recorded yet.